Who is sponsoring PRIMIS?

PRIMIS is sponsored by Gilead Sciences.

What condition does PRIMIS study?

PRIMIS studies Primary Sclerosing Cholangitis.

What drugs are being tested in PRIMIS?

Interventions: Cilofexor, Placebo.

What is the status of PRIMIS?

PRIMIS is currently TERMINATED.

Last reviewed 2023-11-29 · How we verify

Study of Cilofexor in Adults With Primary Sclerosing Cholangitis (PRIMIS)

NCT03890120 PHASE3 TERMINATED Results posted

The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

Details

Lead sponsor	Gilead Sciences
Phase	PHASE3
Status	TERMINATED
Enrolment	419
Start date	Wed Mar 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Primary Sclerosing Cholangitis

Interventions

Cilofexor
Placebo

Countries

Denmark, France, Finland, Italy, Japan, New Zealand, Belgium, Austria, United Kingdom, Germany, Israel, Canada, Switzerland, Australia, United States, Spain